Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/35096
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHickey M.J.en
dc.contributor.authorKumar K.P.en
dc.contributor.authorSepehrizadeh T.en
dc.contributor.authorWong C.H.Y.en
dc.contributor.authorDeVeer M.en
dc.contributor.authorPoole D.P.en
dc.date.accessioned2021-05-14T11:51:10Zen
dc.date.available2021-05-14T11:51:10Zen
dc.date.copyright2020en
dc.date.created20200727en
dc.date.issued2020-07-27en
dc.identifier.citationNeurogastroenterology and Motility. Conference: 4th Meeting of the Federation of Neurogastroenterology and Motility. Adelaide, SA Australia. 32 (Supplement 1`) (no pagination), 2020. Date of Publication: March 2020.en
dc.identifier.issn1365-2982en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/35096en
dc.description.abstractStroke is a debilitating disease caused by a restriction of blood flow to the brain, and it contributes to over 10% of all deaths annually. Despite early mortality being primarily attributed to the extent of brain infarction, stroke is associated with various non-neurological medical complications. Bacterial pneumonia is a common cause of death in patients with stroke. In addition, bowel dysfunction, such as constipation and incontinence, occurs in over half of all patients with stroke. Emerging research suggests that the onset of infection after stroke arises as a consequence of gastrointestinal dysfunction; however, the mechanisms involved remain unclear. This study aims to examine the effect of stroke on the neurons of the enteric nervous system and intestinal immune compositions. Using the well-established mouse model of stroke called the middle cerebral artery occlusion (MCAO), the gut of C57BL6/J mice that either underwent sham or stroke surgery was assessed. At 24 hours after stroke onset, we observed significantly reduced gut transit; however, there were no significant changes between the number or size of peristaltic contractions in vivo between the sham-operated and post-stroke group. Visualisation of the myenteric plexus through fluorescent staining revealed selective changes in neuronal populations. Furthermore, we assessed the immune population in the intestine via flow cytometry and revealed that stroke promotes an increase of immune cells in the ileum, more specifically macrophages in both the mucosal and myenteric plexus layer. Depletion of macrophages showed moderate rescue of altered gut transit after stroke suggesting stroke-induced gut dysmotility is accompanied by neural and immune changes. Addressing the mechanisms that drive gut dysfunction after stroke could aid in the identification of novel therapeutic targets to reduce gut-derived infection in patients with stroke and improve their outcome.en
dc.languageenen
dc.languageEnglishen
dc.publisherBlackwell Publishing Ltden
dc.relation.ispartofNeurogastroenterology and Motilityen
dc.subject.meshmiddle cerebral artery occlusion-
dc.subject.meshmyenteric plexus-
dc.subject.meshnerve cell-
dc.subject.meshsurgery-
dc.subject.meshC57BL 6-
dc.subject.meshcerebrovascular accident-
dc.subject.meshconstipation-
dc.subject.meshdigestive system function disorder-
dc.subject.meshflow cytometry-
dc.subject.meshileum-
dc.subject.meshimmunocompetent cell-
dc.subject.meshin vivo study-
dc.subject.meshincontinence-
dc.subject.meshintestine innervation-
dc.subject.meshintestine motility-
dc.subject.meshmacrophage-
dc.titleAssessment of gut dysfunction in a mouse model of stroke.en
dc.typeConference Abstracten
dc.identifier.affiliationMonash University - School of Biomedical Sciences-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/nmo.13817-
local.date.conferencestart2020-03-25en
dc.identifier.source632078789en
dc.identifier.institution(Kumar, Hickey, Wong) Department of Medicine, Monash Medical Centre, Centre for Inflammatory Diseases, Monash University, Clayton, VIC, Australia (Sepehrizadeh, DeVeer) Monash Biomedical Imaging, Monash University, Clayton, VIC, Australia (Poole) Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, Australiaen
dc.description.addressK.P. Kumar, Department of Medicine, Monash Medical Centre, Centre for Inflammatory Diseases, Monash University, Clayton, VIC, Australiaen
dc.description.publicationstatusCONFERENCE ABSTRACTen
local.date.conferenceend2020-03-28en
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
dc.identifier.affiliationext(Sepehrizadeh, DeVeer) Monash Biomedical Imaging, Monash University, Clayton, VIC, Australia-
dc.identifier.affiliationext(Poole) Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, Australia-
dc.identifier.affiliationmh(Kumar, Hickey, Wong) Department of Medicine, Monash Medical Centre, Centre for Inflammatory Diseases, Monash University, Clayton, VIC, Australia-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeConference Abstract-
Appears in Collections:Conferences
Show simple item record

Page view(s)

20
checked on Feb 7, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.